Dr. Pikman on Implications of a Matched Targeted Therapy Approach in Pediatric Leukemia
February 28th 2019Yana Pikman, MD, a physician in the Cancer and Blood Disorders Center at Dana-Farber Cancer Institute and instructor of pediatrics at Harvard Medical School, discusses the implications of a matched targeted therapy approach in pediatric leukemia.
Read More
Dr. Pikman on Matching Pediatric Patients With More Precise Leukemia Therapy
December 28th 2018Yana Pikman, MD, a physician in the Cancer and Blood Disorders Center at Dana-Farber Cancer Institute and instructor of pediatrics at Harvard Medical School, discusses a trial attempting to match pediatric patients with more precise therapy for acute leukemia.
Read More